Qlik Gallery is meant to encourage Qlikkies everywhere to share their progress – from a first Qlik app – to a favorite Qlik app – and everything in-between. There’s pride in every project no matter where you are in your Qlik journey.
Run through the mobile food facility permits in San Francisco in an intuitive visualization of the official data provided by the city's Public Works department. For each vendor and location, quickly see the current status of the permit (approved, expired, inactive, issued, requested, or suspended), as well as the dates when the application was received and approved, and when the permit is set to expire.
Some of the discoveries from using this app include: * Key milestones in the food permit application process for all mobile vendors, including when it was requested, approved, and expires. * Current application status and timeline for each vendor.
Makes it easy to understand which mobile vendors actually possess an official food permit from San Francisco city authorities, identifying violators endangering public health, as well as to plan timely inspections, renewals, and other procedures established by law.
Authorities overseeing mobile food safety and operations. People willing to know if a certain vendor has the required permit. All who want to analyze resource allocation in Qlik Sense — the app features a good example of a Resource Gantt chart and is publicly available among AnyChart demo apps for QS.
Data and advanced analytics
The dataset is derived from a report on mobile food facility permits, which is provided by the San Francisco Department of Public Works and publicly available online.
Grab a clear picture of the active clinical research studies conducted at Roswell Park Cancer Institute (RPCI) and how they progress. For each of the five most common types of cancer by primary anatomic site of origin, learn what trials are ongoing and intuitively understand which ones are closer to completion than others. Explore by cancer type, current phase, protocol, principal investigator, or start year.
Some of the discoveries from using this app include: * Ongoing clinical trials by phase (Early I, I/ I/II, II, II/III, and III) and location (breast, colon, lung, prostate, and stomach). * Details of each study: protocol, start year, and principal investigator.
Provides a comprehensive big picture of the ongoing clinical research studies across all phases, showing at a glance which trials are about to be completed or lag behind and therefore facilitating the process of setting priorities and making critical decisions.
Pharmaceutical company managers and clinical research directors tracking progress across multiple trials. All who want to monitor progress towards goals in Qlik Sense — the app features a good example of a Bullseye chart and is publicly available among AnyChart demo apps for Qlik Sense.
Data and advanced analytics
The dataset is derived from the list of active clinical studies submitted by the Roswell Park Cancer Institute (RPCI) to the U.S. National Cancer Institute (NCI), which is publicly available online.
Plan your projects across multiple groups and phases to stay on track!
Quickly see tasks to complete, explore the live Gantt view, collaborate with your co-workers using Teamwork, and even update task progress, milestones, and more with Writeback. Vizlib Tiles is even used to create a Kanban-style board for tasks. Move from read-only project plans into a living project planning tool to help you run smoothly. Works with data from JIRA, Microsoft Project, etc. Or build your entire project data set in the Qlik application using writeback. No need for an external planning tool.
For Russian-speaking audience we have a short introductory video (3,5 munites, in Russian, basics on how to work with Risk Monitor app): https://youtu.be/ZRmzP6mhqxk
"Risk Monitor" is a joint project of Deloitte CIS, Qlik Russia and CIS, QUBData. The application is available both in Russian and in English, and integrates 47 data sources (open data and Deloitte’s data) and provides monitoring for Covid-19 pandemic impact on demographics, economics and manufacturing trends throughout the world.